Cookie Einstellungen

Zur Optimierung der Benutzerfreundlichkeit setzen wir Cookies ein. Wählen Sie aus, welche Cookies diese Webseite verwenden darf.  Datenschutzerklärung

Tracking-, Analyse- und technisch erforderliche Cookies.

Nur technisch erforderliche Cookies, die für die grundlegenden Funktionen unserer Webseite nötig sind, werden gesetzt.

Search

Ascenion's COVID-19 related portfolio

Ascenion would like to present to you our portfolio of COVID-19 related technologies in a virtual format. This will be the first part of a series of portfolio presentations. The webinar will take place via Zoom on Wednesday, 6th May.

Ascenion’s Technology Managers will be introducing the following projects:

COVID-19 related portfolio

06.05.2020
3 pm - 4 pm UTC+2


Therapeutics of COVID-19 and COVID-19 related conditions

  • COVID-19
    23-00080 - Therapeutic Neutralizing Antibodies for Treatment of COVID19 Infection

  • Antivirals
    02-00337 - Novel labyrinthopeptins as anti-viral agents

  • Bacterial Secondary Infection
    02-00311 - Cystobactamides – novel antibacterials against gram-negative pathogens

Vaccine Technologies

  • 02-00158 - Cyclic di-Nucleotides as adjuvants

Diagnostic Technologies

  • 02-00375 - TRACR Detect – novel platform technology for RNA detection based on CRISPR/Cas technology
  • 01-00897 - Lateral flow immunoassay with covalently clustered particles for enhanced sensitivity       

Research Tools

  • 07-00081 - Research tools for COVID-19
     

Registration for this event is closed!

 

Back to overview

Kontakt

Communication & Event Management
Stanislava Zollner

T: +49 89 318814-14
zollner@ascenion.de